Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, August 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
LabSmith Provides Hands-On Experience for Microfluidics Short Course at SLAS 2012, San Diego
Tuesday, January 03, 2012
The company will contribute equipment and expertise for participants at the conference, by holding a two-day course, Saturday through Sunday. LabSmith will introduce microfluidics technology and its applications for the life sciences.

LabSmith Provides Hands-On Experience for Microfluidics Short Course at SLAS 2012
Thursday, December 29, 2011
Microfluidics I/II short course will introduce microfluidics technology and its applications for the life sciences.

Randox Biochip Array Technology is the Leading Methodology for Drug Detection in Oral Fluid
Tuesday, December 27, 2011
Offers a diagnostic grade testing solution with reliable and reproducible results.

Hamamatsu Photonics Introduces New C11708MA
Monday, December 26, 2011
New thumb-sized MOEMS mini-spectrometer for infrared spectrometry.

Quanterix Develops Microfluidic Consumable That Will Enable Next Generation Molecular Diagnostic Systems
Friday, December 23, 2011
The company is enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array (SiMoA™) technology, reported a method for detecting individual proteins within microfabricated polymer arrays produced by Sony DADC.

Dolomite Launches New Microfluidic System Enabling Nanoparticle Synthesis
Monday, December 19, 2011
Syringe-based Nanoparticle System allow users to generate polymeric, metal and semi-conductor nanoparticles.

Dolomite Launches new Microfluidic System Enabling Nanoparticle Synthesis
Monday, December 19, 2011
The extended range of System Solutions will include an innovative Syringe-based Nanoparticle System allowing users to generate polymeric, metal and semi-conductor nanoparticles from 1nm to 100nm in diameter.

Gyros Expands Commercial Reach in Asia
Wednesday, December 07, 2011
Gyros AB announces that Binex Co., Ltd., a Contract Development & Manufacturing Organizationfor biotechnology products in the Asian-Pacific region, has purchased a Gyrolab™ workstation.

Dolomite Launches Novel Microfluidic Device for Advanced Cell Immobilization and Observation
Wednesday, December 07, 2011
In collaboration with The Gurdon Institute (University of Cambridge), Dolomite has introduced the Embryo Immobilisation Chip ideal for the immobilization and observation of embryos or cell aggregates of up to 150µm in diameter.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 1043
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv
Go to Lab-on-a-Chip RSS Feed